Kintara Therapeutics announced that Robert E. Hoffman, the company's chairman, will succeed Saiid Zarrabian as Chief Executive Officer, effective November 8, 2021. Hoffman will continue in his capacity as the company's chairman, and Zarrabian will transition to heading up the company?s strategic partnerships initiative and will remain a member of the board of directors. Robert E. Hoffman has served as a director of the company since April 2018 and Chairman since June 2018. He currently serves as a board member of Aslan Pharmaceuticals, Inc., Antibe Therapeutics, Inc., and Saniona AB. Hoffman's previous experience includes serving as Senior Vice President and Chief Financial Officer of Heron Therapeutics from April 2017 to October 2020. Hoffman was part of the founding management team of Arena Pharmaceuticals, Inc. in 1997, serving in various roles until 2015, including Senior Vice President, Finance and Chief Financial Officer. Hoffman served as a member of the Financial Accounting Standards Board's Small Business Advisory Committee.